dapagliflozin
Showing 1 - 25 of 219
STEMI Trial in Cairo (Dapagliflozin)
Recruiting
- STEMI
- Dapagliflozin
-
Cairo, EgyptHelwan University
Jul 16, 2023
Atrial Fibrillation Recurrence, Cox Maze IV, Atrial Fibrillation Trial (Dapagliflozin, Placebo)
Not yet recruiting
- Atrial Fibrillation Recurrence
- +3 more
- Dapagliflozin
- Placebo
- (no location specified)
Apr 16, 2023
End-stage Kidney Disease Trial (Dapagliflozin)
Not yet recruiting
- End-stage Kidney Disease
- Dapagliflozin
- (no location specified)
Jan 5, 2023
Polycystic Ovary Syndrome Trial in Guangzhou (Dapagliflozin, Placebo)
Completed
- Polycystic Ovary Syndrome
- Dapagliflozin
- Placebo
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medical University
Jan 11, 2023
Compensated Cirrhosis, Decompensated Cirrhosis Trial in New Delhi (Metformin, Sitagliptin, Dapagliflozin)
Not yet recruiting
- Compensated Cirrhosis
- Decompensated Cirrhosis
- Metformin
- +2 more
-
New Delhi, Delhi, IndiaDr Rakesh Kumar Jagdish
Nov 23, 2023
Chronic Kidney Failure in Children and Young Adults Trial (Dapagliflozin, Placebo)
Not yet recruiting
- Chronic Kidney Failure in Children and Young Adults
- Dapagliflozin
- Placebo
- (no location specified)
Jul 10, 2023
NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)
Not yet recruiting
- NAFLD Cirrhosis
- Dapagliflozin
- Standard of Care
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
May 5, 2023
Heart Failure With Preserved Ejection Fraction Trial in Rochester (Dapagliflozin, Placebo)
Completed
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 28, 2022
Heart Failure Trial (Dapagliflozin, Placebo)
Not yet recruiting
- Heart Failure
- Dapagliflozin
- Placebo
- (no location specified)
Sep 19, 2022
Healthy Volunteers Trial in Berlin (Semaglutide, Dapagliflozin, Semaglutide/dapagliflozin)
Recruiting
- Healthy Volunteers
- Semaglutide
- +2 more
-
Berlin, Brandenburg, GermanyNovo Nordisk Investigational Site
Aug 10, 2022
Nonalcoholic Steatohepatitis Trial in Guangzhou (Dapagliflozin, Placebo)
Recruiting
- Nonalcoholic Steatohepatitis
- Dapagliflozin
- Placebo
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medical University
Oct 21, 2022
Heart Failure, Reduced Ejection Fraction Trial in Paris (Dapagliflozin)
Recruiting
- Heart Failure
- Reduced Ejection Fraction
- Dapagliflozin
-
Paris, FrancePitié-Salpêtrière Hospital
Dec 7, 2022
Rheumatic Heart Disease, Heart Failure, Mitral Stenosis Trial in Sukoharjo (Dapagliflozin)
Not yet recruiting
- Rheumatic Heart Disease
- +2 more
- Dapagliflozin
-
Sukoharjo, Central Java, IndonesiaSebelas Maret University Hospital
Nov 16, 2022
Diabetes, Type 2, Cardiac Surgery Trial in Beijing (Dapagliflozin)
Recruiting
- Diabetes Mellitus, Type 2
- Cardiac Surgery
- Dapagliflozin
-
Beijing, Beijing, ChinaNational Clinical Research Center for Cardiovascular Diseases, S
Nov 10, 2022
Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,
Completed
- Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
- Dapagliflozin/sitagliptin FDC
- +2 more
-
Berlin, GermanyResearch Site
Jun 30, 2022
Heart Failure,Congestive Trial in Zurich (Dapagliflozin, Placebo)
Recruiting
- Heart Failure,Congestive
- Dapagliflozin
- Placebo
-
Zurich, SwitzerlandUniversity Heart Center Zurich
Aug 19, 2022
Functional Mitral Regurgitation Trial in Guangzhou, Guanzhou (dapagliflozin)
Recruiting
- Functional Mitral Regurgitation
- dapagliflozin
-
Guangzhou, Guangdong, China
- +2 more
Apr 27, 2023
Proteinuria Trial in Shanghai (Dapagliflozin)
Completed
- Proteinuria
- Dapagliflozin
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Jun 17, 2022
Diabetes Trial in Singapore (Dapagliflozin, MetFORMIN 500 Mg Oral Tablet, Dapagliflozin / metFORMIN Pill)
Recruiting
- Diabetes
- Dapagliflozin
- +2 more
-
Singapore, SingaporeTan Tock Seng Hospital
Jun 29, 2022
Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg
Not yet recruiting
- Type2diabetes
- Insulin Resistance
- Metformin
- +2 more
- (no location specified)
Oct 20, 2022
Urolithiasis, Hyperoxaluria Trial in Vienna (Dapagliflozin, Hydrochlorothiazide)
Not yet recruiting
- Urolithiasis
- Hyperoxaluria
- Dapagliflozin
- Hydrochlorothiazide
-
Vienna, AustriaMedical University of Vienna
Jun 29, 2022
Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Dapagliflozin
- Placebo
-
San Antonio, TexasUniversity of Texas Health Science Center
Aug 5, 2022
Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- +2 more
-
Porto, Portugal
- +1 more
Jan 12, 2023
Functional Mitral Regurgitation Trial in Guangzhou (Dapagliflozin, guideline-directed medical therapy (GDMT))
Recruiting
- Functional Mitral Regurgitation
- Dapagliflozin
- guideline-directed medical therapy (GDMT)
-
Guangzhou, Guangdong, China
- +2 more
Nov 4, 2022
Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)
Enrolling by invitation
- Chronic Kidney Diseases
- Zibotentan
- +3 more
-
Aurora, Colorado
- +5 more
Oct 18, 2022